SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics

Dulcie Lai1,2, Paulina Sosicka3, Damian J Williams2

  • 1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.

PubMed
Summary

Loss of function variants in SLC35A2 disrupt brain development and neural network function. This leads to altered neuronal differentiation and synaptic activity, impacting brain network integrity.